

01 Nov 2025
// PRESS RELEASE

06 Oct 2025
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216484

11 Sep 2025
// PHARMAWEB
https://www.pharmiweb.com/press-release/2025-09-11/oncozenge-ab-appoints-link-medical-as-cro-for-bupizenge-phase-iii-execution

30 Jul 2025
// FDA
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-30-2025-84785.pdf

09 Jul 2025
// FDA
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-9-2025-1119.pdf

02 Jul 2025
// FDA
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-2-2025-91897.pdf